Getinge AB (MIL:1GETI) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1GETI Getinge AB MIL:1GETI
52 GF Score
Price €20.90
GF Value €17.65
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Getinge AB Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

MIL:1GETI
52GF Score
Getinge AB MIL:1GETI
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Getinge AB (MIL:1GETI) Overvalued in 2026?

Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued. The current stock price of €20.90 is trading 18.4% above its estimated GF Value™ of €17.65. GuruFocus considers Getinge AB to be Modestly Overvalued.

Key valuation signals for MIL:1GETI:

  • Cash Payments:
  • GF Value™: €17.65 vs. price of €20.90 (18.4% above fair value)
  • GF Score™: 52/100 with 10 warning signs

No single metric tells the full story. See the MIL:1GETI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Getinge AB Business Description

Address Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, 417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
52GF Score

Get the complete analysis for MIL:1GETI

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.90
Price
€17.65
GF Value